Premier educational sessions include experts who helped discover groundbreaking new class of drugs known as JAK inhibitors to treat patients with alopecia areata NEW YORK, Dec. 1, 2022 /PRNewswire/ --

Nonprofit professionals and industry experts can submit proposals through March 1st INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Event and online fundraising leader OneCause today announced its call...

Join cybersecurity leaders from across the industry on December 6 to highlight best practices and recap trends in cyber risk for 2022 TEL AVIV, Israel, Dec. 1, 2022 /PRNewswire/ -- Vulcan Cyber®,...

Demonstrations to focus on model-informed precision dosing and how it helps drive better patient outcomes and boost hospitals' bottom lines SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- Today,...

AMG 133 is a First-in-Class Investigational Bispecific Molecule That Activates GLP-1R and Inhibits GIPR Phase 1 Results Showed up to 14.5% Reduction in Body Weight at the Highest Dose After 12...